DSV Panalpina A/S
DSV, 866 - TRANSACTIONS IN DSV PANALPINA A/S SHARES MADE BY EXECUTIVES
Company Announcement No. 866
DSV Panalpina A/S hereby provides notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in DSV Panalpina A/S made by executives.
Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.
DSV Panalpina A/S
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
DBV Technologies S.A.1.3.2021 07:31:28 CET | Press release
DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021
ORPHAZYME A/S1.3.2021 07:02:06 CET | Press release
Orphazyme appoints Christophe Bourdon as Chief Executive Officer
Idorsia Pharmaceuticals Ltd1.3.2021 07:01:56 CET | Press release
Idorsia submits NDA for clazosentan to Japanese PMDA
Hexagon Composites ASA1.3.2021 07:01:46 CET | Press release
Hexagon Agility receives additional order from major global logistics customer for CNG trucks
Santhera Pharmaceuticals Holding AG1.3.2021 07:01:36 CET | Press release
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
Arcadis N.V.1.3.2021 07:01:26 CET | Press release
Arcadis finds U.S., Singapore, and Japan most attractive places to build data centers
Junshi Biosciences1.3.2021 02:16:51 CET | Press release
Junshi Biosciences and AstraZeneca Announce Strategic Collaboration to Commercialize Toripalimab in China
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom